Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor

  1. Schram, A.
  2. Borad, M.
  3. Sahai, V.
  4. Kamath, S.
  5. Kim, R.
  6. Liao, C.Y.A.
  7. Oh, D.Y.
  8. Ponz-Sarvisé, M.
  9. Yachnin, J.
  10. Shell, S.A.
  11. Cassier, P.
  12. Dotan, E.
  13. Florou, V.
  14. Moreno, V.
  15. Park, J.O.
  16. Tai, D.
  17. Schmidt-Kittler, O.
  18. Ferté, C.
  19. Goyal, L.
  20. Subbiah, V.
Revista:
European Journal of Cancer

ISSN: 1879-0852,  0959-8049

Any de publicació: 2022

Títol de l'exemplar: 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Volum: 174

Pàgines: S116

Tipus: Article

DOI: 10.1016/S0959-8049(22)01110-8 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus